These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1431 related articles for article (PubMed ID: 29268783)
21. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300 [TBL] [Abstract][Full Text] [Related]
22. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742 [TBL] [Abstract][Full Text] [Related]
23. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Wang Y; Chen L; Zhang B; Song W; Zhou G; Xie L; Yu D Front Oncol; 2021; 11():639909. PubMed ID: 33816284 [TBL] [Abstract][Full Text] [Related]
24. Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer. Park BK; Park JW; Han EC; Ryoo SB; Han SW; Kim TY; Chie EK; Jeong SY; Park KJ J Surg Oncol; 2016 Aug; 114(2):216-21. PubMed ID: 27222402 [TBL] [Abstract][Full Text] [Related]
25. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934 [TBL] [Abstract][Full Text] [Related]
26. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843 [TBL] [Abstract][Full Text] [Related]
27. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. Akgül Ö; Çetinkaya E; Yalaza M; Özden S; Tez M World J Gastrointest Oncol; 2017 Jul; 9(7):300-307. PubMed ID: 28808503 [TBL] [Abstract][Full Text] [Related]
28. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Wang J; Liu Y; Mi X; Shao M; Liu L Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the preoperative prognostic nutritional index in oldest-old patients with colorectal cancer. Tominaga T; Nonaka T; Hisanaga M; Fukuda A; Tanoue Y; Yoshimoto T; Hidaka S; Sawai T; Nagayasu T Surg Today; 2020 May; 50(5):449-459. PubMed ID: 31720800 [TBL] [Abstract][Full Text] [Related]
30. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer. Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375 [TBL] [Abstract][Full Text] [Related]
31. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer. Shimizu T; Taniguchi K; Asakuma M; Tomioka A; Inoue Y; Komeda K; Hirokawa F; Uchiyama K Anticancer Res; 2019 Apr; 39(4):2169-2176. PubMed ID: 30952764 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study. Xu T; Zhang SM; Wu HM; Wen XM; Qiu DQ; Yang YY; Wang LZ; Zhu WB; He LS; Li JJ BMC Cancer; 2022 Nov; 22(1):1128. PubMed ID: 36329394 [TBL] [Abstract][Full Text] [Related]
33. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
34. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597 [TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients. Zhang L; Deng Y; Liu S; Zhang W; Hong Z; Lu Z; Pan Z; Wu X; Peng J BMC Cancer; 2023 Jan; 23(1):3. PubMed ID: 36593480 [TBL] [Abstract][Full Text] [Related]
36. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer. Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247 [TBL] [Abstract][Full Text] [Related]
38. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy. Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798 [TBL] [Abstract][Full Text] [Related]
39. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma. Huang X; Hu H; Zhang W; Shao Z J Cell Physiol; 2019 Aug; 234(10):18408-18414. PubMed ID: 30891768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]